Oxygenta Pharmaceutical Ltd — Updates, 18-04-2025: Company Update

Oxygenta Pharmaceutical Limited has confirmed compliance with SEBI regulations regarding dematerialised securities, as per a certificate issued by its Registrar and Transfer Agent. The certificate verifies the verification and cancellation of securities received for dematerialisation for the fourth quarter and the financial year ending March 31, 2025. This update reflects the company's commitment to regulatory adherence and operational efficiency in managing shareholder records. Investors may view this as a positive outlook on the company's governance practices, signalling robust compliance measures that support transparency and investor confidence.